LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 307 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,789,006 | +16.7% | 33,100 | +1.2% | 0.00% | 0.0% |
| Q1 2024 | $2,390,370 | +3.0% | 32,700 | +0.6% | 0.00% | 0.0% |
| Q4 2023 | $2,321,150 | +7.3% | 32,500 | -10.0% | 0.00% | 0.0% |
| Q3 2023 | $2,163,112 | -15.0% | 36,100 | +2.3% | 0.00% | 0.0% |
| Q2 2023 | $2,545,130 | -5.2% | 35,300 | -3.3% | 0.00% | 0.0% |
| Q1 2023 | $2,684,940 | -1.2% | 36,500 | -10.3% | 0.00% | 0.0% |
| Q4 2022 | $2,718,760 | -21.1% | 40,700 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $3,444,000 | -2.3% | 40,000 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $3,524,000 | -20.7% | 39,500 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $4,443,000 | -21.6% | 39,500 | +7.6% | 0.00% | 0.0% |
| Q4 2021 | $5,669,000 | +10.6% | 36,700 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $5,127,000 | +6.8% | 36,800 | +0.5% | 0.00% | 0.0% |
| Q2 2021 | $4,802,000 | -14.4% | 36,600 | -0.5% | 0.00% | -25.0% |
| Q1 2021 | $5,610,000 | +55.0% | 36,800 | +1.1% | 0.00% | +33.3% |
| Q4 2020 | $3,620,000 | +4.3% | 36,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,470,000 | -15.7% | 36,400 | -1.1% | 0.00% | 0.0% |
| Q2 2020 | $4,116,000 | +66.0% | 36,800 | +7.9% | 0.00% | 0.0% |
| Q1 2020 | $2,480,000 | -34.7% | 34,100 | -6.3% | 0.00% | -25.0% |
| Q4 2019 | $3,796,000 | +3.9% | 36,400 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $3,653,000 | -15.8% | 36,700 | -3.4% | 0.00% | -20.0% |
| Q2 2019 | $4,338,000 | -11.1% | 38,000 | -2.1% | 0.01% | 0.0% |
| Q1 2019 | $4,878,000 | -3.4% | 38,800 | +4.3% | 0.01% | -16.7% |
| Q4 2018 | $5,048,000 | -50.6% | 37,200 | 0.0% | 0.01% | -45.5% |
| Q3 2018 | $10,211,000 | +34.3% | 37,200 | +1.4% | 0.01% | +22.2% |
| Q2 2018 | $7,603,000 | +25.4% | 36,700 | 0.0% | 0.01% | +28.6% |
| Q1 2018 | $6,061,000 | +21.6% | 36,700 | +0.8% | 0.01% | +40.0% |
| Q4 2017 | $4,984,000 | +4.9% | 36,400 | +4.3% | 0.01% | 0.0% |
| Q3 2017 | $4,752,000 | +12.2% | 34,900 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $4,237,000 | +22.8% | 34,900 | +7.1% | 0.01% | +25.0% |
| Q1 2017 | $3,450,000 | +6.1% | 32,600 | +1.9% | 0.00% | -20.0% |
| Q4 2016 | $3,252,000 | -0.4% | 32,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $3,266,000 | -14.7% | 32,000 | -0.3% | 0.01% | -16.7% |
| Q2 2016 | $3,829,000 | +24.7% | 32,100 | +8.1% | 0.01% | 0.0% |
| Q1 2016 | $3,070,000 | +21.0% | 29,700 | +26.9% | 0.01% | 0.0% |
| Q4 2015 | $2,537,000 | +26.6% | 23,400 | 0.0% | 0.01% | +20.0% |
| Q3 2015 | $2,004,000 | -2.1% | 23,400 | +15.3% | 0.01% | 0.0% |
| Q2 2015 | $2,048,000 | +42.0% | 20,300 | +8.6% | 0.01% | +25.0% |
| Q1 2015 | $1,442,000 | +44.9% | 18,700 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $995,000 | +13.2% | 18,700 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $879,000 | -24.5% | 18,700 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $1,165,000 | -15.1% | 18,700 | -8.3% | 0.00% | -20.0% |
| Q1 2014 | $1,372,000 | +66.1% | 20,400 | +29.9% | 0.01% | +66.7% |
| Q4 2013 | $826,000 | +5.5% | 15,700 | -13.3% | 0.00% | 0.0% |
| Q3 2013 | $783,000 | +10.1% | 18,100 | -4.7% | 0.00% | 0.0% |
| Q2 2013 | $711,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |